- references:
  - doi: 10.4049/jimmunol.2000583
    refId: Alsoussi20
    firstAuthor:
      surname: Alsoussi
      givenNames: Wafaa B.
    year: 2020
    journal: The Journal of Immunology
    journalShort: J.I.
  - doi: 10.1016/j.cell.2020.06.011
    refId: Hassan20
    firstAuthor:
      surname: Hassan
      givenNames: Ahmed O.
    year: 2020
    journal: Cell
  antibodies: 1B07
  source: |-
    Plasmablasts from mice immunized with RBD and trimeric spike.
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV2-9-1
  shm: 0
  cdrh3_len: '15'
  iglv: IGLV1
  ic50: '37'
  epitope_class: ''
- references:
  - doi: 10.4049/jimmunol.2000583
    refId: Alsoussi20
    firstAuthor:
      surname: Alsoussi
      givenNames: Wafaa B.
    year: 2020
    journal: The Journal of Immunology
    journalShort: J.I.
  - doi: 10.1016/j.cell.2020.06.011
    refId: Hassan20
    firstAuthor:
      surname: Hassan
      givenNames: Ahmed O.
    year: 2020
    journal: Cell
  antibodies: 2B04
  source: |-
    Plasmablasts from mice immunized with RBD and trimeric spike.
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV2-9-1
  shm: 3
  cdrh3_len: '14'
  iglv: IGLV1
  ic50: '1.5'
  epitope_class: ''
- references:
  - doi: 10.4049/jimmunol.2000583
    refId: Alsoussi20
    firstAuthor:
      surname: Alsoussi
      givenNames: Wafaa B.
    year: 2020
    journal: The Journal of Immunology
    journalShort: J.I.
  - doi: 10.1016/j.cell.2020.06.011
    refId: Hassan20
    firstAuthor:
      surname: Hassan
      givenNames: Ahmed O.
    year: 2020
    journal: Cell
  antibodies: 2H04
  source: |-
    Plasmablasts from mice immunized with RBD and trimeric spike.
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-55
  shm: 6
  cdrh3_len: '13'
  iglv: IGKV5-48
  ic50: '300'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-16256-y
    refId: Wang20b
    firstAuthor:
      surname: Wang
      givenNames: Chunyan
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  - doi: 10.1101/2020.08.24.264630
    refId: Haagmans20
    firstAuthor:
      surname: Haagmans
      givenNames: Bart L.
    year: 2020
    journal: bioRxiv
  - doi: 10.1101/2020.09.30.318261
    refId: Fedry20
    firstAuthor:
      surname: Fedry
      givenNames: Juliette
    year: 2020
    journal: bioRxiv
  antibodies: 47D11
  source: |-
    Hybridomas from humanized H2L2 transgenic mice immunized with trimeric S from SARS-CoV-1, MERS-CoV, and HCoV-OC43 (SARS-CoV-2 RBD)
  status: animal model
  type: mAb
  pdb: 7AKD
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '570'
  epitope_class: ''
- references:
  - doi: 10.1073/pnas.2010197117
    refId: Li20b
    firstAuthor:
      surname: Li
      givenNames: Wei
    year: 2020
    journal: Proceedings of the National Academy of Sciences
    journalShort: Proc Natl Acad Sci USA
  antibodies: ab1
  source: |-
    Na√Øve B cell Fab and scFv phage display library (RBD)
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV3-53
  shm: 0
  cdrh3_len: '11'
  iglv: IGKV4-1
  ic50: '195'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc2241
    refId: Wu20
    firstAuthor:
      surname: Wu
      givenNames: Yan
    year: 2020
    journal: Science
  antibodies: B38
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: animal model
  type: mAb
  pdb: 7BZ5
  ighv: IGHV3-53
  shm: 1
  cdrh3_len: '9'
  iglv: IGKV1-9
  ic50: '180'
  epitope_class: RBM 1
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-23
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 7BYR
  ighv: IGHV7-4-1
  shm: 0
  cdrh3_len: '19'
  iglv: IGKV1-5
  ic50: ''
  epitope_class: RBM 3
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-236
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 7CHB
  ighv: IGHV3-53
  shm: 3
  cdrh3_len: '12'
  iglv: ''
  ic50: ''
  epitope_class: RBM 1
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-368-2
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 7CHH
  ighv: IGHV3-23
  shm: 9
  cdrh3_len: '18'
  iglv: IGKV2-28
  ic50: '15'
  epitope_class: RBM 2
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-503
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV3-53
  shm: ''
  cdrh3_len: '11'
  iglv: IGKV1-39
  ic50: '140'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-508
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV3-53
  shm: ''
  cdrh3_len: '11'
  iglv: IGKV1-39
  ic50: '290'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-515
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV3-66
  shm: ''
  cdrh3_len: ''
  iglv: IGKV1-39
  ic50: '200'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-602
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 11, PV
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-604
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 7CH4
  ighv: IGHV3-53
  shm: 5
  cdrh3_len: '11'
  iglv: ''
  ic50: '5'
  epitope_class: RBM 1
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-606
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '6'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-612
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '18'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-617
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '9'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-629
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 7CH5
  ighv: IGHV3-53
  shm: 4
  cdrh3_len: '11'
  iglv: IGKV3-20
  ic50: '4'
  epitope_class: RBM 1
- references:
  - doi: 10.1016/j.cell.2020.05.025
    refId: Cao20c
    firstAuthor:
      surname: Cao
      givenNames: Yunlong
    year: 2020
    journal: Cell
  - doi: 10.1016/j.cell.2020.09.035
    refId: Du20
    firstAuthor:
      surname: Du
      givenNames: Shuo
    year: 2020
    journal: Cell
  antibodies: BD-632
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '17'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc7520
    refId: Rogers20
    firstAuthor:
      surname: Rogers
      givenNames: Thomas F.
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd2321
    refId: Yuan20c
    firstAuthor:
      surname: Yuan
      givenNames: Meng
    year: 2020
    journal: Science
  antibodies: CC12.1
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 6XC2
  ighv: IGHV3-53
  shm: 2
  cdrh3_len: '11'
  iglv: IGKV1-9
  ic50: '46'
  epitope_class: RBM 1
- references:
  - doi: 10.1126/science.abc7520
    refId: Rogers20
    firstAuthor:
      surname: Rogers
      givenNames: Thomas F.
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd2321
    refId: Yuan20c
    firstAuthor:
      surname: Yuan
      givenNames: Meng
    year: 2020
    journal: Science
  antibodies: CC12.3
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: 6XC4
  ighv: IGHV3-53
  shm: 4
  cdrh3_len: '11'
  iglv: IGKV3-20
  ic50: ''
  epitope_class: RBM 1
- references:
  - doi: 10.1126/science.abc7520
    refId: Rogers20
    firstAuthor:
      surname: Rogers
      givenNames: Thomas F.
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd2321
    refId: Yuan20c
    firstAuthor:
      surname: Yuan
      givenNames: Meng
    year: 2020
    journal: Science
  antibodies: CC6.29
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV7-4-1
  shm: 8
  cdrh3_len: '15'
  iglv: IGKV1-39
  ic50: 2, PV
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc7520
    refId: Rogers20
    firstAuthor:
      surname: Rogers
      givenNames: Thomas F.
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd2321
    refId: Yuan20c
    firstAuthor:
      surname: Yuan
      givenNames: Meng
    year: 2020
    journal: Science
  antibodies: CC6.30
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-69
  shm: 3
  cdrh3_len: '18'
  iglv: IGKV1-39
  ic50: 1, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: COV2-2050
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-2
  shm: 4
  cdrh3_len: '23'
  iglv: IGLV1-44
  ic50: '125'
  epitope_class: ''
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: COV2-2050-LALA-PG
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '157'
  epitope_class: ''
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: COV2-2381
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-58
  shm: 2
  cdrh3_len: '16'
  iglv: IGKV3-20
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: COV2-3025
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-58
  shm: 4
  cdrh3_len: '16'
  iglv: IGKV3-20
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: COV2-3025-LALA-PG
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.09.049
    refId: Kreye20
    firstAuthor:
      surname: Kreye
      givenNames: Jakob
    year: 2020
    journal: Cell
  antibodies: CV07-209
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV3-11
  shm: 1
  cdrh3_len: '12'
  iglv: IGKV1-33
  ic50: '3.1'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.09.049
    refId: Kreye20
    firstAuthor:
      surname: Kreye
      givenNames: Jakob
    year: 2020
    journal: Cell
  antibodies: CV07-270
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: animal model
  type: mAb
  pdb: 6XKP
  ighv: IGHV3-11
  shm: ''
  cdrh3_len: '22'
  iglv: IGKV2-14
  ic50: '82'
  epitope_class: RBM 2
- references:
  - doi: 10.1126/science.abc2241
    refId: Wu20
    firstAuthor:
      surname: Wu
      givenNames: Yan
    year: 2020
    journal: Science
  antibodies: H4
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-2
  shm: 0
  cdrh3_len: '19'
  iglv: IGKV2-40
  ic50: '900'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-19568-1
    refId: Wang20l
    firstAuthor:
      surname: Wang
      givenNames: Shuang
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: MW05
  source: |-
    Convalescent memory B cells (SARS-CoV-2 RBD) engineered to have LALA mutations.
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 1000, IC100
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-19568-1
    refId: Wang20l
    firstAuthor:
      surname: Wang
      givenNames: Shuang
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: MW07
  source: |-
    Convalescent memory B cells (SARS-CoV-2 RBD) engineered to have LALA mutations.
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 5000, IC100
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-19568-1
    refId: Wang20l
    firstAuthor:
      surname: Wang
      givenNames: Shuang
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: MW33
  source: |-
    Convalescent memory B cells (SARS-CoV-2 RBD) engineered to have LALA mutations.
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1126/science.abd0827
    refId: Hansen20
    firstAuthor:
      surname: Hansen
      givenNames: Johanna
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd0831
    refId: Baum20
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  - doi: 10.1126/science.abe2402
    refId: Baum20b
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  antibodies: REGN10934
  source: |-
    Transgenic VelocImmune mice immunized with SARS-CoV-2 trimeric S and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV3-15
  shm: 1
  cdrh3_len: '11'
  iglv: IGKV1-33
  ic50: '4.5'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abd0827
    refId: Hansen20
    firstAuthor:
      surname: Hansen
      givenNames: Johanna
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd0831
    refId: Baum20
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  - doi: 10.1126/science.abe2402
    refId: Baum20b
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  antibodies: REGN10989
  source: |-
    Transgenic VelocImmune mice immunized with SARS-CoV-2 trimeric S and RBD
  status: animal model
  type: mAb
  pdb: ''
  ighv: IGHV1-2
  shm: 6
  cdrh3_len: '16'
  iglv: IGLV2-14
  ic50: '1.1'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe3354
    refId: Tortorici20
    firstAuthor:
      surname: Tortorici
      givenNames: M. Alejandra
    year: 2020
    journal: Science
  antibodies: S2E12
  source: |-
    Convalescent memory B cells (SARS-CoV-2 trimeric spike)
  status: animal model
  type: mAb
  pdb: 7K4N
  ighv: IGHV1-58
  shm: 4
  cdrh3_len: '16'
  iglv: IGKV3-20
  ic50: '4.2'
  epitope_class: RBM 1
- references:
  - doi: 10.1126/science.abe3354
    refId: Tortorici20
    firstAuthor:
      surname: Tortorici
      givenNames: M. Alejandra
    year: 2020
    journal: Science
  antibodies: S2M11
  source: |-
    Convalescent memory B cells (SARS-CoV-2 trimeric spike)
  status: animal model
  type: mAb
  pdb: 7K43
  ighv: IGHV1-2
  shm: 7
  cdrh3_len: '18'
  iglv: IGKV3-20
  ic50: '1.2'
  epitope_class: RBM 3
- references:
  - doi: 10.1101/2020.10.26.355107
    refId: Chan20b
    firstAuthor:
      surname: Chan
      givenNames: Conrad E.Z.
    year: 2020
    journal: bioRxiv
  antibodies: SC31
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2670'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.27.316174
    refId: Cao20f
    firstAuthor:
      surname: Cao
      givenNames: Xia
    year: 2020
    journal: bioRxiv
  antibodies: STI-1499
  source: |-
    Phage display scFv library created from na√Øve individuals screened for S1 binding and inhibition of S1-ACE2 binding.
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '3000'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.27.316174
    refId: Cao20f
    firstAuthor:
      surname: Cao
      givenNames: Xia
    year: 2020
    journal: bioRxiv
  antibodies: STI-2020
  source: |-
    Phage display scFv library created from na√Øve individuals screened for S1 binding and inhibition of S1-ACE2 binding.
  status: animal model
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '55'
  epitope_class: ''
- references: []
  antibodies: Bamlanivimab + Etesevimab
  status: EUA
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.30.318972
    refId: Jones20
    firstAuthor:
      surname: Jones
      givenNames: Bryan E.
    year: 2020
    journal: bioRxiv
  - doi: 10.1038/s41586-020-2381-y
    refId: Shi20
    firstAuthor:
      surname: Shi
      givenNames: Rui
    year: 2020
    journal: Nature
  - doi: 10.1056/NEJMoa2029849
    refId: Chen20l
    firstAuthor:
      surname: Chen
      givenNames: Peter
    year: 2020
    journal: New England Journal of Medicine
    journalShort: N Engl J Med
  antibodies: Bamlanivimab, LY-CoV555, LY3819253
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: EUA
  type: mAb
  pdb: 7KMG
  ighv: IGHV1-69
  shm: 1
  cdrh3_len: '18'
  iglv: IGKV1-39
  ic50: '10'
  epitope_class: RBM 2
- references:
  - doi: 10.1126/science.abd0827
    refId: Hansen20
    firstAuthor:
      surname: Hansen
      givenNames: Johanna
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd0831
    refId: Baum20
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  - doi: 10.1126/science.abe2402
    refId: Baum20b
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  antibodies: Casirivimab, REGN10933
  source: |-
    Transgenic VelocImmune mice immunized with SARS-CoV-2 trimeric S and RBD
  status: EUA
  type: mAb
  pdb: 6XDG
  ighv: IGHV3-11
  shm: 3
  cdrh3_len: '13'
  iglv: IGKV1-33
  ic50: '8'
  epitope_class: RBM 1
- references:
  - doi: 10.1038/s41586-020-2381-y
    refId: Shi20
    firstAuthor:
      surname: Shi
      givenNames: Rui
    year: 2020
    journal: Nature
  antibodies: Etesevimab, LY-CoV016, LY3832479, JS016, CB6
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: EUA
  type: mAb
  pdb: 7C01
  ighv: IGHV3-66
  shm: 3
  cdrh3_len: '13'
  iglv: IGKV1-39
  ic50: '835'
  epitope_class: RBM 1
- references:
  - doi: 10.1126/science.abd0827
    refId: Hansen20
    firstAuthor:
      surname: Hansen
      givenNames: Johanna
    year: 2020
    journal: Science
  - doi: 10.1126/science.abd0831
    refId: Baum20
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  - doi: 10.1126/science.abe2402
    refId: Baum20b
    firstAuthor:
      surname: Baum
      givenNames: Alina
    year: 2020
    journal: Science
  antibodies: Imdevimab, REGN10987
  source: |-
    Transgenic VelocImmune mice immunized with SARS-CoV-2 trimeric S and RBD
  status: EUA
  type: mAb
  pdb: 6XDG
  ighv: IGHV3-30
  shm: 3
  cdrh3_len: '13'
  iglv: IGLV2-14
  ic50: '6'
  epitope_class: RBD Core 1
- references: []
  antibodies: REGN-COV2 (Casirivimab + Imdevimab)
  status: EUA
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-20602-5
    refId: Kim21
    firstAuthor:
      surname: Kim
      givenNames: Cheolmin
    year: 2021
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: CT-P59
  source: |-
    scFv phage display library of uncertain origin selected for RBD binding
  status: EUA(in SK)
  type: mAb
  pdb: 7CM4
  ighv: IGHV2-70
  shm: 10
  cdrh3_len: '20'
  iglv: IGLV1-51
  ic50: '8.4'
  epitope_class: RBM 1
- references: []
  antibodies: ABBV-47D11
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: Adintrevimab
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: ADM03820
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2456-9
    refId: Robbiani20
    firstAuthor:
      surname: Robbiani
      givenNames: Davide F.
    year: 2020
    journal: Nature
  - doi: 10.1016/j.cell.2020.06.025
    refId: Barnes20
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Cell
  - doi: 10.7554/eLife.61312
    refId: Weisblum20
    firstAuthor:
      surname: Weisblum
      givenNames: Yiska
    year: 2020
    journal: eLife
  - doi: 10.1038/s41586-020-2852-1
    refId: Barnes20b
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Nature
  antibodies: C135
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: Phase1
  type: mAb
  pdb: 7K8Z
  ighv: IGHV3-30
  shm: 4
  cdrh3_len: '12'
  iglv: IGKV1-5
  ic50: 3, PV
  epitope_class: RBD Core 1
- references:
  - doi: 10.1038/s41586-020-2456-9
    refId: Robbiani20
    firstAuthor:
      surname: Robbiani
      givenNames: Davide F.
    year: 2020
    journal: Nature
  - doi: 10.1016/j.cell.2020.06.025
    refId: Barnes20
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Cell
  - doi: 10.7554/eLife.61312
    refId: Weisblum20
    firstAuthor:
      surname: Weisblum
      givenNames: Yiska
    year: 2020
    journal: eLife
  - doi: 10.1038/s41586-020-2852-1
    refId: Barnes20b
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Nature
  antibodies: C144
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: Phase1
  type: mAb
  pdb: 7K90
  ighv: IGHV3-53
  shm: 3
  cdrh3_len: '25'
  iglv: IGLV2-14
  ic50: 2.6, PV
  epitope_class: RBM 3
- references: []
  antibodies: C144-LS + C-135-LS
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: DXP604
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: HFB30132A
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: HLX70
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: JMB2002
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: LY-CovMab
  status: Phase1
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: COR-101
  status: Phase1/2
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: BI 767551, DZIF-10c
  status: Phase1/2
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: COVI-AMG (STI-2020)
  status: Phase2
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: DXP593
  status: Phase2
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: MW33
  status: Phase2
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: SCTA01
  status: Phase2/3
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2349-y
    refId: Pinto20
    firstAuthor:
      surname: Pinto
      givenNames: Dora
    year: 2020
    journal: Nature
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: Sotrovimab, Vir-7831, S309, GSK4182136
  source: |-
    SARS-CoV-1 convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD(Pinto20). bnAbs ADI-55688, 55689 and 56046 (see Wec20)(Rappazzo21)
  status: Phase2/3
  type: mAb
  pdb: 6WPS
  ighv: IGHV1-18
  shm: 6
  cdrh3_len: '20'
  iglv: IGKV3-20
  ic50: 80(Pinto20), 240(Rappazzo21)
  epitope_class: RBD Core 1
- references: []
  antibodies: AZD7442 (Tixagevimab + Cilgavimab)
  status: Phase3
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: BRII-196
  status: Phase3
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references: []
  antibodies: BRII-198
  status: Phase3
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: Cilgavimab, COV2-2130, AZD1061
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: Phase3
  type: mAb
  pdb: 7L7E
  ighv: IGHV3-15
  shm: 4
  cdrh3_len: '22'
  iglv: IGKV4-1
  ic50: '105'
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41591-020-0998-x
    refId: Zost20
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature Medicine
    journalShort: Nat Med
  - doi: 10.1038/s41586-020-2548-6
    refId: Zost20b
    firstAuthor:
      surname: Zost
      givenNames: Seth J.
    year: 2020
    journal: Nature
  - doi: 10.1101/2020.12.28.424554
    refId: Winkler20
    firstAuthor:
      surname: Winkler
      givenNames: Emma S.
    year: 2020
    journal: bioRxiv
  antibodies: Tixagevimab, COV2-2196, AZD8895
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD and trimeric spike
  status: Phase3
  type: mAb
  pdb: 7L7D
  ighv: IGHV1-58
  shm: 2
  cdrh3_len: '16'
  iglv: IGKV3-20
  ic50: '15'
  epitope_class: RBM 1
- references: []
  antibodies: TY027
  status: Phase3
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc6952
    refId: Chi20
    firstAuthor:
      surname: Chi
      givenNames: Xiangyang
    year: 2020
    journal: Science
  antibodies: 0304-3H3
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV4-59
  shm: 4
  cdrh3_len: '18'
  iglv: IGKV3-15
  ic50: '40'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.10.20.346916
    refId: Wang21c
    firstAuthor:
      surname: Wang
      givenNames: Chunyan
    year: 2020
    journal: bioRxiv
  antibodies: 1.6C7
  source: |-
    Transgenic H2L2 mice that encode the human immunoglobulin repertoire were used for immunization to develop fully human antibodies
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '83'
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 1-20
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-53
  shm: 2
  cdrh3_len: '11'
  iglv: IGKV1-9
  ic50: '7.5'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.11.292631
    refId: Li20e
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  - doi: 10.1101/2020.08.19.253369
    refId: Han20b
    firstAuthor:
      surname: Han
      givenNames: Xiaojian
    year: 2020
    journal: bioRxiv
  antibodies: 13G9
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '7'
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 1-57
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7LS9
  ighv: IGHV3-72
  shm: 2
  cdrh3_len: '21'
  iglv: IGKV3-20
  ic50: '7.5'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: '1E2'
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-30
  shm: 18
  cdrh3_len: '14'
  iglv: ''
  ic50: '240'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 1E2-FC
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '43'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.14.203414
    refId: Wang20h
    firstAuthor:
      surname: Wang
      givenNames: Bei
    year: 2020
    journal: bioRxiv
  antibodies: 1F6
  source: |-
    Human B cell phage display library filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 2-15
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7L5B
  ighv: IGHV1-2
  shm: 5
  cdrh3_len: '22'
  iglv: IGLV2-14
  ic50: '0.8'
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 2-17
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV1-69
  shm: 1
  cdrh3_len: '17'
  iglv: IGKV3-15
  ic50: '6'
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 2-4
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 6XEY
  ighv: IGHV1-2
  shm: 3
  cdrh3_len: '15'
  iglv: IGLV2-8
  ic50: ''
  epitope_class: RBM 3
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 2-43
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV1-2
  shm: 2
  cdrh3_len: '22'
  iglv: IGLV2-14
  ic50: ''
  epitope_class: RBD Core 1
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 2-7
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7LSS
  ighv: IGHV2-5
  shm: 0
  cdrh3_len: '11'
  iglv: IGLV2-14
  ic50: '3'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.10.20.346916
    refId: Wang21c
    firstAuthor:
      surname: Wang
      givenNames: Chunyan
    year: 2020
    journal: bioRxiv
  antibodies: 28D9
  source: |-
    Transgenic H2L2 mice that encode the human immunoglobulin repertoire were used for immunization to develop fully human antibodies
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '930'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 2F2
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-23
  shm: 17
  cdrh3_len: '18'
  iglv: ''
  ic50: '294'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 2F2-Fc
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '32'
  epitope_class: ''
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: 2G3
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '32'
  epitope_class: ''
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: 2H2
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: 7DK5
  ighv: IGHV2-5-1
  shm: 3
  cdrh3_len: '11'
  iglv: IGKV3-10
  ic50: '7'
  epitope_class: RBM 1
- references:
  - doi: 10.1101/2020.07.14.203414
    refId: Wang20h
    firstAuthor:
      surname: Wang
      givenNames: Bei
    year: 2020
    journal: bioRxiv
  antibodies: 2H4
  source: |-
    Human B cell phage display library filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41423-020-0426-7
    refId: Chen20e
    firstAuthor:
      surname: Chen
      givenNames: Xiangyu
    year: 2020
    journal: Cellular & Molecular Immunology
    journalShort: Cell Mol Immunol
  antibodies: 311mab-31B5
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: '19'
  iglv: ''
  ic50: 34, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41423-020-0426-7
    refId: Chen20e
    firstAuthor:
      surname: Chen
      givenNames: Xiangyu
    year: 2020
    journal: Cellular & Molecular Immunology
    journalShort: Cell Mol Immunol
  antibodies: 311mab-32D4
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: '15'
  iglv: ''
  ic50: 70, PV
  epitope_class: ''
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: 3C1
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: 7DD2
  ighv: IGHV3S1
  shm: 4
  cdrh3_len: '13'
  iglv: IGKV6-23
  ic50: '3127'
  epitope_class: RBD Core 2
- references:
  - doi: 10.1101/2020.07.14.203414
    refId: Wang20h
    firstAuthor:
      surname: Wang
      givenNames: Bei
    year: 2020
    journal: bioRxiv
  antibodies: 3D11
  source: |-
    Human B cell phage display library filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 3F11
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-23
  shm: 20
  cdrh3_len: '18'
  iglv: ''
  ic50: '372'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.14.203414
    refId: Wang20h
    firstAuthor:
      surname: Wang
      givenNames: Bei
    year: 2020
    journal: bioRxiv
  antibodies: 3F11
  source: |-
    Human B cell phage display library filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-23
  shm: 20
  cdrh3_len: '18'
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 3F11-Fc
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '1'
  epitope_class: ''
- references:
  - doi: 10.1016/j.celrep.2020.107918
    refId: Wan20
    firstAuthor:
      surname: Wan
      givenNames: Jinkai
    year: 2020
    journal: Cell Reports
  antibodies: 414-1
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: '19'
  iglv: ''
  ic50: '263'
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 4-8
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV1-69
  shm: 3
  cdrh3_len: '18'
  iglv: IGLV3-1
  ic50: '9'
  epitope_class: NTD
- references:
  - doi: 10.1126/science.abc6952
    refId: Chi20
    firstAuthor:
      surname: Chi
      givenNames: Xiangyang
    year: 2020
    journal: Science
  antibodies: 4A8
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7C2L
  ighv: IGHV1-24
  shm: 3
  cdrh3_len: '21'
  iglv: IGKV2-24
  ic50: '610'
  epitope_class: NTD
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 4D8
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-23
  shm: 18
  cdrh3_len: '18'
  iglv: ''
  ic50: '125'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 4D8-Fc
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '37'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.11.292631
    refId: Li20e
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  - doi: 10.1101/2020.08.19.253369
    refId: Han20b
    firstAuthor:
      surname: Han
      givenNames: Xiaojian
    year: 2020
    journal: bioRxiv
  antibodies: 510A5
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-9
  shm: 2
  cdrh3_len: '16'
  iglv: IGKV1-39
  ic50: '11'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.11.292631
    refId: Li20e
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  - doi: 10.1101/2020.08.19.253369
    refId: Han20b
    firstAuthor:
      surname: Han
      givenNames: Xiaojian
    year: 2020
    journal: bioRxiv
  antibodies: 51D7
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV5-51
  shm: 6
  cdrh3_len: '13'
  iglv: IGKV1-39
  ic50: '39'
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2571-7
    refId: Liu20e
    firstAuthor:
      surname: Liu
      givenNames: Lihong
    year: 2020
    journal: Nature
  antibodies: 5-24
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7L2F
  ighv: IGHV3-33
  shm: 5
  cdrh3_len: '22'
  iglv: IGKV3-20
  ic50: '7.5'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.09.11.292631
    refId: Li20e
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  - doi: 10.1101/2020.08.19.253369
    refId: Han20b
    firstAuthor:
      surname: Han
      givenNames: Xiaojian
    year: 2020
    journal: bioRxiv
  antibodies: 58G6
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV1-58
  shm: 4
  cdrh3_len: '16'
  iglv: IGKV3-20
  ic50: '10'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.14.203414
    refId: Wang20h
    firstAuthor:
      surname: Wang
      givenNames: Bei
    year: 2020
    journal: bioRxiv
  antibodies: 5A6
  source: |-
    Human B cell phage display library filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '141'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 5F8
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-30
  shm: 16
  cdrh3_len: '18'
  iglv: ''
  ic50: '511'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18387-8
    refId: Chi20b
    firstAuthor:
      surname: Chi
      givenNames: Xiaojing
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: 5F8-Fc
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '4'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.14.203414
    refId: Wang20h
    firstAuthor:
      surname: Wang
      givenNames: Bei
    year: 2020
    journal: bioRxiv
  antibodies: 6F8
  source: |-
    Human B cell phage display library filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1101/2020.06.14.147868
    refId: Miao20
    firstAuthor:
      surname: Miao
      givenNames: Xiaoniu
    year: 2020
    journal: bioRxiv
  antibodies: 89C8
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1101/2020.06.14.147868
    refId: Miao20
    firstAuthor:
      surname: Miao
      givenNames: Xiaoniu
    year: 2020
    journal: bioRxiv
  antibodies: 89C8-ACE2
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: 8D3
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '71'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: ADG-1
  source: |-
    bnAbs ADI-55688, 55689 and 56046 (see Wec20)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '42'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: ADG-2
  source: |-
    bnAbs ADI-55688, 55689 and 56046 (see Wec20)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '8'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: ADG-3
  source: |-
    bnAbs ADI-55688, 55689 and 56046 (see Wec20)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '47'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: ADI-55688
  source: |-
    bnAbs ADI-55688, 55689 and 56046 (see Wec20)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '21'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc7424
    refId: Wec20
    firstAuthor:
      surname: Wec
      givenNames: Anna Z.
    year: 2020
    journal: Science
  antibodies: ADI-55688
  source: |-
    SARS-CoV-1 convalescent memory B cells filtered for binding to SARS-CoV-2 tetrameric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '190'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: ADI-55689
  source: |-
    bnAbs ADI-55688, 55689 and 56046 (see Wec20)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '37'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc7424
    refId: Wec20
    firstAuthor:
      surname: Wec
      givenNames: Anna Z.
    year: 2020
    journal: Science
  antibodies: ADI-55689
  source: |-
    SARS-CoV-1 convalescent memory B cells filtered for binding to SARS-CoV-2 tetrameric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '100'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc7424
    refId: Wec20
    firstAuthor:
      surname: Wec
      givenNames: Anna Z.
    year: 2020
    journal: Science
  antibodies: ADI-56000
  source: |-
    SARS-CoV-1 convalescent memory B cells filtered for binding to SARS-CoV-2 tetrameric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '120'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abf4830
    refId: Rappazzo21
    firstAuthor:
      surname: Rappazzo
      givenNames: C. Garrett
    year: 2021
    journal: Science
  antibodies: ADI-56046
  source: |-
    bnAbs ADI-55688, 55689 and 56046 (see Wec20)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '140'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc7424
    refId: Wec20
    firstAuthor:
      surname: Wec
      givenNames: Anna Z.
    year: 2020
    journal: Science
  antibodies: ADI-56046
  source: |-
    SARS-CoV-1 convalescent memory B cells filtered for binding to SARS-CoV-2 tetrameric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '100'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.12.29.424482
    refId: Veesler20
    firstAuthor:
      surname: Sauer
      givenNames: Maximilian M.
    year: 2020
    journal: bioRxiv
  antibodies: B6
  source: |-
    Mice immunized with MERS-CoV trimeric S followed by SARS-CoV trimeric S
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: biNb3-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 755.7, PV
  epitope_class: ''
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: biNb91-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 1239.7, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2456-9
    refId: Robbiani20
    firstAuthor:
      surname: Robbiani
      givenNames: Davide F.
    year: 2020
    journal: Nature
  - doi: 10.1016/j.cell.2020.06.025
    refId: Barnes20
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Cell
  - doi: 10.7554/eLife.61312
    refId: Weisblum20
    firstAuthor:
      surname: Weisblum
      givenNames: Yiska
    year: 2020
    journal: eLife
  - doi: 10.1038/s41586-020-2852-1
    refId: Barnes20b
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Nature
  antibodies: C002
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: 7K8S
  ighv: IGHV3-30
  shm: 2
  cdrh3_len: '17'
  iglv: IGKV1-39
  ic50: 8.9, PV
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41586-020-2456-9
    refId: Robbiani20
    firstAuthor:
      surname: Robbiani
      givenNames: Davide F.
    year: 2020
    journal: Nature
  - doi: 10.1016/j.cell.2020.06.025
    refId: Barnes20
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Cell
  - doi: 10.7554/eLife.61312
    refId: Weisblum20
    firstAuthor:
      surname: Weisblum
      givenNames: Yiska
    year: 2020
    journal: eLife
  - doi: 10.1038/s41586-020-2852-1
    refId: Barnes20b
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Nature
  antibodies: C104
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: 7K8U
  ighv: IGHV4-34
  shm: 6
  cdrh3_len: '17'
  iglv: IGKV3-20
  ic50: ''
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41586-020-2456-9
    refId: Robbiani20
    firstAuthor:
      surname: Robbiani
      givenNames: Davide F.
    year: 2020
    journal: Nature
  - doi: 10.1016/j.cell.2020.06.025
    refId: Barnes20
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Cell
  - doi: 10.7554/eLife.61312
    refId: Weisblum20
    firstAuthor:
      surname: Weisblum
      givenNames: Yiska
    year: 2020
    journal: eLife
  - doi: 10.1038/s41586-020-2852-1
    refId: Barnes20b
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Nature
  antibodies: C105
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: 6XCN
  ighv: IGHV3-53
  shm: 1
  cdrh3_len: '12'
  iglv: IGLV2-8
  ic50: 26.1, PV
  epitope_class: RBM 1
- references:
  - doi: 10.1038/s41586-020-2456-9
    refId: Robbiani20
    firstAuthor:
      surname: Robbiani
      givenNames: Davide F.
    year: 2020
    journal: Nature
  - doi: 10.1016/j.cell.2020.06.025
    refId: Barnes20
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Cell
  - doi: 10.7554/eLife.61312
    refId: Weisblum20
    firstAuthor:
      surname: Weisblum
      givenNames: Yiska
    year: 2020
    journal: eLife
  - doi: 10.1038/s41586-020-2852-1
    refId: Barnes20b
    firstAuthor:
      surname: Barnes
      givenNames: Christopher O.
    year: 2020
    journal: Nature
  antibodies: C121
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: 7K8X
  ighv: IGHV1-2
  shm: 2
  cdrh3_len: '22'
  iglv: IGLV2-23
  ic50: 1.6, PV
  epitope_class: RBM 2
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: c2H2
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '22'
  epitope_class: ''
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: c3C1
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '286'
  epitope_class: ''
- references:
  - doi: 10.1101/2021.01.18.21249786
    refId: Zhang21
    firstAuthor:
      surname: Zhang
      givenNames: Wenjuan
    year: 2021
    journal: medRxiv
  antibodies: c3C1+c2H2
  source: |-
    mice immunized with a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG Fc (RBD-mFc) by using the conventional hybridoma technology
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '12'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc5902
    refId: Brouwer20
    firstAuthor:
      surname: Brouwer
      givenNames: Philip J. M.
    year: 2020
    journal: Science
  - doi: 10.1016/j.celrep.2020.108274
    refId: Wu20c
    firstAuthor:
      surname: Wu
      givenNames: Nicholas C.
    year: 2020
    journal: Cell Reports
  - doi: 10.1016/j.immuni.2020.10.023
    refId: Liu20g
    firstAuthor:
      surname: Liu
      givenNames: Hejun
    year: 2020
    journal: Immunity
  antibodies: COVA1-16
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7JMW
  ighv: IGHV1-46
  shm: 1
  cdrh3_len: '22'
  iglv: IGKV1-33
  ic50: '745'
  epitope_class: RBD Core 2
- references:
  - doi: 10.1126/science.abc5902
    refId: Brouwer20
    firstAuthor:
      surname: Brouwer
      givenNames: Philip J. M.
    year: 2020
    journal: Science
  - doi: 10.1016/j.celrep.2020.108274
    refId: Wu20c
    firstAuthor:
      surname: Wu
      givenNames: Nicholas C.
    year: 2020
    journal: Cell Reports
  - doi: 10.1016/j.immuni.2020.10.023
    refId: Liu20g
    firstAuthor:
      surname: Liu
      givenNames: Hejun
    year: 2020
    journal: Immunity
  antibodies: COVA1-18
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-66
  shm: 0
  cdrh3_len: '12'
  iglv: IGLV7-46
  ic50: '7'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc5902
    refId: Brouwer20
    firstAuthor:
      surname: Brouwer
      givenNames: Philip J. M.
    year: 2020
    journal: Science
  - doi: 10.1016/j.celrep.2020.108274
    refId: Wu20c
    firstAuthor:
      surname: Wu
      givenNames: Nicholas C.
    year: 2020
    journal: Cell Reports
  - doi: 10.1016/j.immuni.2020.10.023
    refId: Liu20g
    firstAuthor:
      surname: Liu
      givenNames: Hejun
    year: 2020
    journal: Immunity
  antibodies: COVA2-04
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7JMO
  ighv: IGHV3-53
  shm: 2
  cdrh3_len: '12'
  iglv: IGKV3-20
  ic50: '2500'
  epitope_class: RBM 1
- references:
  - doi: 10.1126/science.abc5902
    refId: Brouwer20
    firstAuthor:
      surname: Brouwer
      givenNames: Philip J. M.
    year: 2020
    journal: Science
  - doi: 10.1016/j.celrep.2020.108274
    refId: Wu20c
    firstAuthor:
      surname: Wu
      givenNames: Nicholas C.
    year: 2020
    journal: Cell Reports
  - doi: 10.1016/j.immuni.2020.10.023
    refId: Liu20g
    firstAuthor:
      surname: Liu
      givenNames: Hejun
    year: 2020
    journal: Immunity
  antibodies: COVA2-15
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-23
  shm: 3
  cdrh3_len: '22'
  iglv: IGKV2-30
  ic50: '9'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc5902
    refId: Brouwer20
    firstAuthor:
      surname: Brouwer
      givenNames: Philip J. M.
    year: 2020
    journal: Science
  - doi: 10.1016/j.celrep.2020.108274
    refId: Wu20c
    firstAuthor:
      surname: Wu
      givenNames: Nicholas C.
    year: 2020
    journal: Cell Reports
  - doi: 10.1016/j.immuni.2020.10.023
    refId: Liu20g
    firstAuthor:
      surname: Liu
      givenNames: Hejun
    year: 2020
    journal: Immunity
  antibodies: COVA2-39
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: 7JMP
  ighv: IGHV3-53
  shm: 3
  cdrh3_len: '17'
  iglv: IGLV2-23
  ic50: '54'
  epitope_class: RBM 1
- references:
  - doi: 10.1371/journal.pmed.0030237
    refId: terMeulen06
    firstAuthor:
      surname: ter Meulen
      givenNames: Jan
    year: 2006
    journal: PLoS Medicine
    journalShort: PLoS Med
  - doi: 10.1126/science.abb7269
    refId: Yuan20b
    firstAuthor:
      surname: Yuan
      givenNames: Meng
    year: 2020
    journal: Science
  - doi: 10.1016/j.chom.2020.06.010
    refId: Huo20
    firstAuthor:
      surname: Huo
      givenNames: Jiandong
    year: 2020
    journal: Cell Host & Microbe
  antibodies: CR3022
  source: |-
    SARS-CoV-1 scFv phage display library (irradiated SARS-Cov-1)
  status: ''
  type: mAb
  pdb: 6YLA
  ighv: IGHV5-51
  shm: 9
  cdrh3_len: '12'
  iglv: IGKV4-1
  ic50: '114'
  epitope_class: RBD Core 2
- references:
  - doi: 10.1016/j.immuni.2020.06.001
    refId: Seydoux20
    firstAuthor:
      surname: Seydoux
      givenNames: Emilie
    year: 2020
    journal: Immunity
  - doi: 10.1038/s41467-020-19231-9
    refId: Hurlburt20
    firstAuthor:
      surname: Hurlburt
      givenNames: Nicholas K.
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: CV30
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: ''
  type: mAb
  pdb: 6XE1
  ighv: IGHV3-53
  shm: 2
  cdrh3_len: '12'
  iglv: IGKV3-20
  ic50: '118'
  epitope_class: RBM 1
- references:
  - doi: 10.1016/j.immuni.2020.06.001
    refId: Seydoux20
    firstAuthor:
      surname: Seydoux
      givenNames: Emilie
    year: 2020
    journal: Immunity
  - doi: 10.1038/s41467-020-19231-9
    refId: Hurlburt20
    firstAuthor:
      surname: Hurlburt
      givenNames: Nicholas K.
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: CV30-GermLine
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike and RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 13000, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41594-020-0480-y
    refId: Zhou20b
    firstAuthor:
      surname: Zhou
      givenNames: Daming
    year: 2020
    journal: Nature Structural & Molecular Biology
    journalShort: Nat Struct Mol Biol
  antibodies: EY6A
  source: |-
    Plasmablasts from SARS-CoV-2 infected persons filtered for binding to SARS-CoV-2 trimeric spike and S1
  status: ''
  type: mAb
  pdb: 6ZER
  ighv: IGHV3-30
  shm: 3
  cdrh3_len: '14'
  iglv: IGKV1-39
  ic50: '70'
  epitope_class: RBD Core 2
- references:
  - doi: 10.1016/j.cell.2020.06.044
    refId: Kreer20
    firstAuthor:
      surname: Kreer
      givenNames: Christoph
    year: 2020
    journal: Cell
  antibodies: FnC1t2p1_D4
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV7-4-1
  shm: 6
  cdrh3_len: '11'
  iglv: IGKV1-33
  ic50: 280, IC100
  epitope_class: ''
- references:
  - doi: 10.1126/science.abc5881
    refId: Lv20
    firstAuthor:
      surname: Lv
      givenNames: Zhe
    year: 2020
    journal: Science
  antibodies: H014
  source: |-
    Phage display library created from mice immunized with SARS-CoV-1 and SARS-CoV-2 RBD (SARS-CoV-2 RBD) (humanized)
  status: ''
  type: mAb
  pdb: 7CAH
  ighv: IGHV1-69-2
  shm: 20
  cdrh3_len: '13'
  iglv: IGKV6-21
  ic50: '570'
  epitope_class: RBD Core 2
- references:
  - doi: 10.1038/s41594-020-0469-6
    refId: Huo20b
    firstAuthor:
      surname: Huo
      givenNames: Jiandong
    year: 2020
    journal: Nature Structural & Molecular Biology
    journalShort: Nat Struct Mol Biol
  antibodies: H11-D4-Fc
  source: |-
    Phage display sdAb library created from na√Øve llamas. mAbs selected for RBD binding and then fused with an Fc domain.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '1020'
  epitope_class: ''
- references:
  - doi: 10.1038/s41594-020-0469-6
    refId: Huo20b
    firstAuthor:
      surname: Huo
      givenNames: Jiandong
    year: 2020
    journal: Nature Structural & Molecular Biology
    journalShort: Nat Struct Mol Biol
  antibodies: H11-H4
  source: |-
    Phage display sdAb library created from na√Øve llamas. mAbs selected for RBD binding and then fused with an Fc domain.
  status: ''
  type: nanobody
  pdb: 6ZHD
  ighv: IGHV3-3
  shm: 8
  cdrh3_len: '20'
  iglv: ''
  ic50: '600'
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41594-020-0469-6
    refId: Huo20b
    firstAuthor:
      surname: Huo
      givenNames: Jiandong
    year: 2020
    journal: Nature Structural & Molecular Biology
    journalShort: Nat Struct Mol Biol
  antibodies: H11-H4-Fc
  source: |-
    Phage display sdAb library created from na√Øve llamas. mAbs selected for RBD binding and then fused with an Fc domain.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '280'
  epitope_class: ''
- references:
  - doi: 10.1038/s41423-020-0458-z
    refId: Yi20
    firstAuthor:
      surname: Yi
      givenNames: Chunyan
    year: 2020
    journal: Cellular & Molecular Immunology
    journalShort: Cell Mol Immunol
  antibodies: HA001
  source: |-
    Phage display library (uncertain source) selected for SARS-CoV-2 RBD binding
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 16, PV
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.06.044
    refId: Kreer20
    firstAuthor:
      surname: Kreer
      givenNames: Christoph
    year: 2020
    journal: Cell
  antibodies: HbnC3t1p1_C6
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV1-58
  shm: 0
  cdrh3_len: '16'
  iglv: IGKV3-20
  ic50: 40, IC100
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18058-8
    refId: Ejemel20
    firstAuthor:
      surname: Ejemel
      givenNames: Monir
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: mAb-362-IgA
  source: |-
    Transgenic HuMAb mice immunized with SARS-CoV-1 spike (SARS-CoV-2 RBD)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 1260, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18058-8
    refId: Ejemel20
    firstAuthor:
      surname: Ejemel
      givenNames: Monir
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: mAb-362-IgA-dimeric
  source: |-
    Transgenic HuMAb mice immunized with SARS-CoV-1 spike (SARS-CoV-2 RBD)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 30, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18058-8
    refId: Ejemel20
    firstAuthor:
      surname: Ejemel
      givenNames: Monir
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: mAb-362-IgA-secretory
  source: |-
    Transgenic HuMAb mice immunized with SARS-CoV-1 spike (SARS-CoV-2 RBD)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 9500, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18058-8
    refId: Ejemel20
    firstAuthor:
      surname: Ejemel
      givenNames: Monir
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: mAb-362-IgG
  source: |-
    Transgenic HuMAb mice immunized with SARS-CoV-1 spike (SARS-CoV-2 RBD)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '>50000, PV'
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18159-4
    refId: Noy-Porat20
    firstAuthor:
      surname: Noy-Porat
      givenNames: Tal
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: MD65
  source: |-
    Convalescent B cell scFv library filtered from binding to SARS-CoV-2 trimeric spike and RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-66
  shm: ''
  cdrh3_len: '12'
  iglv: IGKV3-20
  ic50: '220'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.06.044
    refId: Kreer20
    firstAuthor:
      surname: Kreer
      givenNames: Christoph
    year: 2020
    journal: Cell
  antibodies: MnC2t1p1_A3
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-66
  shm: 3
  cdrh3_len: '13'
  iglv: IGKV1-12
  ic50: 780, IC100
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.06.044
    refId: Kreer20
    firstAuthor:
      surname: Kreer
      givenNames: Christoph
    year: 2020
    journal: Cell
  antibodies: MnC2t2p1_C11
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV1-69
  shm: 3
  cdrh3_len: '23'
  iglv: IGKV1-39
  ic50: 255, IC100
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.06.044
    refId: Kreer20
    firstAuthor:
      surname: Kreer
      givenNames: Christoph
    year: 2020
    journal: Cell
  antibodies: MnC4t2p1_B3
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 trimeric spike
  status: ''
  type: mAb
  pdb: ''
  ighv: IGHV3-9
  shm: 10
  cdrh3_len: '17'
  iglv: IGKV1-12
  ic50: 660, IC100
  epitope_class: ''
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: monoNb3-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 1779.8, PV
  epitope_class: ''
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: monoNb91-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 2973.85, PV
  epitope_class: ''
- references:
  - doi: 10.1101/2020.06.09.143438
    refId: Li20d
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  antibodies: MR17
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: 7C8W
  ighv: IGHV3S53
  shm: 21
  cdrh3_len: '14'
  iglv: ''
  ic50: 12000, PV
  epitope_class: RBM 2
- references:
  - doi: 10.1101/2020.06.09.143438
    refId: Li20d
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  antibodies: MR17-K99Y
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: 7CAN
  ighv: IGHV3S53
  shm: 21
  cdrh3_len: '14'
  iglv: ''
  ic50: 500, PV
  epitope_class: RBM 2
- references:
  - doi: 10.1101/2020.06.09.143438
    refId: Li20d
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  antibodies: MR3
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: IGHV3S53
  shm: 20
  cdrh3_len: '14'
  iglv: ''
  ic50: 400, PV
  epitope_class: ''
- references:
  - doi: 10.1101/2020.06.09.143438
    refId: Li20d
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  antibodies: MR4
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: IGHV3S53
  shm: 22
  cdrh3_len: '14'
  iglv: ''
  ic50: 740, PV
  epitope_class: ''
- references:
  - doi: 10.1016/j.chom.2020.04.023
    refId: Wu20b
    firstAuthor:
      surname: Wu
      givenNames: Yanling
    year: 2020
    journal: Cell Host & Microbe
  antibodies: n3088
  source: |-
    Human sdAb phage display library (seleccted for binding to S1 and RBD)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2600'
  epitope_class: ''
- references:
  - doi: 10.1016/j.chom.2020.04.023
    refId: Wu20b
    firstAuthor:
      surname: Wu
      givenNames: Yanling
    year: 2020
    journal: Cell Host & Microbe
  antibodies: n3130
  source: |-
    Human sdAb phage display library (seleccted for binding to S1 and RBD)
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '4000'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe3255
    refId: Schoof20
    firstAuthor:
      surname: Schoof
      givenNames: Michael
    year: 2020
    journal: Science
  antibodies: Nb11
  source: |-
    Synthetic phage display sdAb library selected for trimeric spike binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: IGHV3-3
  shm: 14
  cdrh3_len: '12'
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1101/2020.08.09.242867
    refId: Gai20
    firstAuthor:
      surname: Gai
      givenNames: Junwei
    year: 2020
    journal: bioRxiv
  antibodies: Nb11-59
  source: |-
    Phage display library created from camels immunized with RBD and then filtered for RBD binding
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '550'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe4747
    refId: Xiang20
    firstAuthor:
      surname: Xiang
      givenNames: Yufei
    year: 2020
    journal: Science
  antibodies: nb20
  source: |-
    Phage display sdAb library created from llamas immunized with RBD.
  status: ''
  type: nanobody
  pdb: 7JVB
  ighv: IGHV3-3
  shm: 15
  cdrh3_len: '12'
  iglv: ''
  ic50: '0.8'
  epitope_class: RBM 3
- references:
  - doi: 10.1126/science.abe4747
    refId: Xiang20
    firstAuthor:
      surname: Xiang
      givenNames: Yufei
    year: 2020
    journal: Science
  antibodies: nb21
  source: |-
    Phage display sdAb library created from llamas immunized with RBD.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '0.4'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe3255
    refId: Schoof20
    firstAuthor:
      surname: Schoof
      givenNames: Michael
    year: 2020
    journal: Science
  antibodies: Nb6
  source: |-
    Synthetic phage display sdAb library selected for trimeric spike binding.
  status: ''
  type: nanobody
  pdb: 7KKK
  ighv: IGHV3S53
  shm: 17
  cdrh3_len: '12'
  iglv: ''
  ic50: '6300'
  epitope_class: RBM 3
- references:
  - doi: 10.1126/science.abe3255
    refId: Schoof20
    firstAuthor:
      surname: Schoof
      givenNames: Michael
    year: 2020
    journal: Science
  antibodies: Nb6-matured
  source: |-
    Synthetic phage display sdAb library selected for trimeric spike binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '180'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe3255
    refId: Schoof20
    firstAuthor:
      surname: Schoof
      givenNames: Michael
    year: 2020
    journal: Science
  antibodies: Nb6-matured-trimeric
  source: |-
    Synthetic phage display sdAb library selected for trimeric spike binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2.4'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe3255
    refId: Schoof20
    firstAuthor:
      surname: Schoof
      givenNames: Michael
    year: 2020
    journal: Science
  antibodies: Nb6-trimeric
  source: |-
    Synthetic phage display sdAb library selected for trimeric spike binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '45'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe4747
    refId: Xiang20
    firstAuthor:
      surname: Xiang
      givenNames: Yufei
    year: 2020
    journal: Science
  antibodies: nb89
  source: |-
    Phage display sdAb library created from llamas immunized with RBD.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2.4'
  epitope_class: ''
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: Nb91-Nb3-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 169.4, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2380-z
    refId: Ju20
    firstAuthor:
      surname: Ju
      givenNames: Bin
    year: 2020
    journal: Nature
  antibodies: P2B-2F6
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: 7BWJ
  ighv: IGHV4-38-2
  shm: 1
  cdrh3_len: '20'
  iglv: IGLV2-8
  ic50: '410'
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41586-020-2380-z
    refId: Ju20
    firstAuthor:
      surname: Ju
      givenNames: Bin
    year: 2020
    journal: Nature
  antibodies: P2C-1A13
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '280'
  epitope_class: ''
- references:
  - doi: 10.1038/s41586-020-2380-z
    refId: Ju20
    firstAuthor:
      surname: Ju
      givenNames: Bin
    year: 2020
    journal: Nature
  antibodies: P2C-1F11
  source: |-
    Convalescent memory B cells filtered for binding to SARS-CoV-2 RBD
  status: ''
  type: mAb
  pdb: 7CDI
  ighv: IGHV3-66
  shm: 4
  cdrh3_len: '11'
  iglv: IGKV3-20
  ic50: '30'
  epitope_class: RBM 1
- references:
  - doi: 10.1101/2020.10.07.328302
    refId: Andreano20
    firstAuthor:
      surname: Andreano
      givenNames: Emanuele
    year: 2020
    journal: bioRxiv
  antibodies: PT-004
  source: |-
    Convalescent memory B cells (SARS-CoV-2 trimeric spike).
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: <3, IC100
  epitope_class: ''
- references:
  - doi: 10.1101/2020.10.07.328302
    refId: Andreano20
    firstAuthor:
      surname: Andreano
      givenNames: Emanuele
    year: 2020
    journal: bioRxiv
  antibodies: PT-100
  source: |-
    Convalescent memory B cells (SARS-CoV-2 trimeric spike).
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: <3, IC100
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.27.224089
    refId: Beasley20
    firstAuthor:
      surname: Beasley
      givenNames: Matthew D.
    year: 2020
    journal: bioRxiv
  antibodies: RU169-178-diabody
  source: |-
    Retained Display scFv display platform selected for RBD and Spike binding and engineered to produce diabodies and Fc fusions.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2000'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.27.224089
    refId: Beasley20
    firstAuthor:
      surname: Beasley
      givenNames: Matthew D.
    year: 2020
    journal: bioRxiv
  antibodies: RU169-178-IgG
  source: |-
    Retained Display scFv display platform selected for RBD and Spike binding and engineered to produce diabodies and Fc fusions.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '1300'
  epitope_class: ''
- references:
  - doi: 10.1101/2020.07.27.224089
    refId: Beasley20
    firstAuthor:
      surname: Beasley
      givenNames: Matthew D.
    year: 2020
    journal: bioRxiv
  antibodies: RU169-178-scFv
  source: |-
    Retained Display scFv display platform selected for RBD and Spike binding and engineered to produce diabodies and Fc fusions.
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2200'
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.09.037
    refId: Piccoli20
    firstAuthor:
      surname: Piccoli
      givenNames: Luca
    year: 2020
    journal: Cell
  antibodies: S2H13
  source: |-
    Convalescent memory B cells (SARS-CoV-2 trimeric spike)
  status: ''
  type: mAb
  pdb: 7JV6
  ighv: IGHV3-7
  shm: 4
  cdrh3_len: '13'
  iglv: IGLV7-46
  ic50: 500, PV
  epitope_class: RBM 2
- references:
  - doi: 10.1016/j.cell.2020.09.037
    refId: Piccoli20
    firstAuthor:
      surname: Piccoli
      givenNames: Luca
    year: 2020
    journal: Cell
  antibodies: S2H14
  source: |-
    Convalescent memory B cells (SARS-CoV-2 trimeric spike)
  status: ''
  type: mAb
  pdb: 7JX3
  ighv: IGHV3-15
  shm: 0
  cdrh3_len: '17'
  iglv: IGLV6-57
  ic50: 900, PV
  epitope_class: RBM 1
- references:
  - doi: 10.1038/s41467-020-19204-y
    refId: Custodio20
    firstAuthor:
      surname: Cust√≥dio
      givenNames: T√¢nia F.
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: Sb23
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: 7A29
  ighv: IGHV3-3
  shm: 14
  cdrh3_len: '8'
  iglv: ''
  ic50: '600'
  epitope_class: RBM 2
- references:
  - doi: 10.1101/2020.06.09.143438
    refId: Li20d
    firstAuthor:
      surname: Li
      givenNames: Tingting
    year: 2020
    journal: bioRxiv
  antibodies: SR4
  source: |-
    Synthetic phage display sdAb library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: 7C8V
  ighv: IGHV3-3
  shm: 14
  cdrh3_len: '8'
  iglv: ''
  ic50: 5900, PV
  epitope_class: RBM 1
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: triNb3-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 775.5, PV
  epitope_class: ''
- references:
  - doi: 10.1186/s12951-021-00768-w
    refId: Lu21
    firstAuthor:
      surname: Lu
      givenNames: Qizhong
    year: 2021
    journal: Journal of Nanobiotechnology
    journalShort: J Nanobiotechnol
  antibodies: triNb91-hFc
  source: |-
    camel nanobody, +/- Fc fusion, mono- di- or tri-mer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 806.85, PV
  epitope_class: ''
- references:
  - doi: 10.1038/s41467-020-18174-5
    refId: Hanke20
    firstAuthor:
      surname: Hanke
      givenNames: Leo
    year: 2020
    journal: Nature Communications
    journalShort: Nat Commun
  antibodies: Ty1
  source: |-
    Phage display sdAb library created from alpaca immunized with S1-Fc and RBD.
  status: ''
  type: nanobody
  pdb: 6ZXN
  ighv: IGHV3S1
  shm: 17
  cdrh3_len: '11'
  iglv: ''
  ic50: PV, 770
  epitope_class: RBM 2
- references:
  - doi: 10.1038/s41589-020-00679-1
    refId: Bracken20
    firstAuthor:
      surname: Bracken
      givenNames: Colton J.
    year: 2020
    journal: Nature Chemical Biology
    journalShort: Nat Chem Biol
  antibodies: VH2-A01-B01
  source: |-
    Synthetic VH phage display sdAb library selected for RBD binding engineered to form VH2, VH3, and VH-Fc fusions.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '347'
  epitope_class: ''
- references:
  - doi: 10.1038/s41589-020-00679-1
    refId: Bracken20
    firstAuthor:
      surname: Bracken
      givenNames: Colton J.
    year: 2020
    journal: Nature Chemical Biology
    journalShort: Nat Chem Biol
  antibodies: VH2-A01-B02
  source: |-
    Synthetic VH phage display sdAb library selected for RBD binding engineered to form VH2, VH3, and VH-Fc fusions.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '743'
  epitope_class: ''
- references:
  - doi: 10.1038/s41589-020-00679-1
    refId: Bracken20
    firstAuthor:
      surname: Bracken
      givenNames: Colton J.
    year: 2020
    journal: Nature Chemical Biology
    journalShort: Nat Chem Biol
  antibodies: VH3-B01
  source: |-
    Synthetic VH phage display sdAb library selected for RBD binding engineered to form VH2, VH3, and VH-Fc fusions.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '176'
  epitope_class: ''
- references:
  - doi: 10.1080/19420862.2020.1778435
    refId: Sun20
    firstAuthor:
      surname: Sun
      givenNames: Zehua
    year: 2020
    journal: mAbs
  antibodies: VH-Ab6-Fc
  source: |-
    Human sdAb CDR2 and CDR3 VH phage display library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '350'
  epitope_class: ''
- references:
  - doi: 10.1038/s41589-020-00679-1
    refId: Bracken20
    firstAuthor:
      surname: Bracken
      givenNames: Colton J.
    year: 2020
    journal: Nature Chemical Biology
    journalShort: Nat Chem Biol
  antibodies: VH-Fc-B01
  source: |-
    Synthetic VH phage display sdAb library selected for RBD binding engineered to form VH2, VH3, and VH-Fc fusions.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '2613'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe6230
    refId: Koenig21
    firstAuthor:
      surname: Koenig
      givenNames: Paul-Albert
    year: 2021
    journal: Science
  antibodies: VHH E
  source: |-
    alpaca or llama immunized with SARS-CoV-2 spike RBD and inactivated virus
  status: ''
  type: nanobody
  pdb: 7KN5
  ighv: IGHV3-3
  shm: 16
  cdrh3_len: '22'
  iglv: ''
  ic50: '0.72'
  epitope_class: RBM 2
- references:
  - doi: 10.1126/science.abe6230
    refId: Koenig21
    firstAuthor:
      surname: Koenig
      givenNames: Paul-Albert
    year: 2021
    journal: Science
  antibodies: VHH EV
  source: |-
    alpaca or llama immunized with SARS-CoV-2 spike RBD and inactivated virus
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '0.021000'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe6230
    refId: Koenig21
    firstAuthor:
      surname: Koenig
      givenNames: Paul-Albert
    year: 2021
    journal: Science
  antibodies: VHH U
  source: |-
    alpaca or llama immunized with SARS-CoV-2 spike RBD and inactivated virus
  status: ''
  type: nanobody
  pdb: 7KN5
  ighv: IGHV3-3
  shm: 13
  cdrh3_len: '19'
  iglv: ''
  ic50: '2.775'
  epitope_class: RBD Core 1
- references:
  - doi: 10.1126/science.abe6230
    refId: Koenig21
    firstAuthor:
      surname: Koenig
      givenNames: Paul-Albert
    year: 2021
    journal: Science
  antibodies: VHH V
  source: |-
    alpaca or llama immunized with SARS-CoV-2 spike RBD and inactivated virus
  status: ''
  type: nanobody
  pdb: 7KN6
  ighv: IGHV3S1
  shm: 12
  cdrh3_len: '15'
  iglv: ''
  ic50: '2.13'
  epitope_class: RBD Core 1
- references:
  - doi: 10.1126/science.abe6230
    refId: Koenig21
    firstAuthor:
      surname: Koenig
      givenNames: Paul-Albert
    year: 2021
    journal: Science
  antibodies: VHH VE
  source: |-
    alpaca or llama immunized with SARS-CoV-2 spike RBD and inactivated virus
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '0.039600'
  epitope_class: ''
- references:
  - doi: 10.1126/science.abe6230
    refId: Koenig21
    firstAuthor:
      surname: Koenig
      givenNames: Paul-Albert
    year: 2021
    journal: Science
  antibodies: VHH W
  source: |-
    alpaca or llama immunized with SARS-CoV-2 spike RBD and inactivated virus
  status: ''
  type: nanobody
  pdb: 7KN7
  ighv: IGHV3-3
  shm: 13
  cdrh3_len: '19'
  iglv: ''
  ic50: '1.215'
  epitope_class: RBD Core 1
- references:
  - doi: 10.1016/j.cell.2020.04.031
    refId: Wrapp20
    firstAuthor:
      surname: Wrapp
      givenNames: Daniel
    year: 2020
    journal: Cell
  antibodies: VHH-55
  source: |-
    Phage display sdAb library created from llamas immunized with SARS-CoV-1 and MERS-CoV trimeric spike. mAbs selected for binding to SARS-CoV-1 or MERS-CoV spike.
  status: ''
  type: nanobody
  pdb: 6WAR
  ighv: IGHV3S53
  shm: 24
  cdrh3_len: '14'
  iglv: ''
  ic50: ''
  epitope_class: ''
- references:
  - doi: 10.1016/j.cell.2020.04.031
    refId: Wrapp20
    firstAuthor:
      surname: Wrapp
      givenNames: Daniel
    year: 2020
    journal: Cell
  antibodies: VHH-72-Fc
  source: |-
    Phage display sdAb library created from llamas immunized with SARS-CoV-1 and MERS-CoV trimeric spike. mAbs selected for binding to SARS-CoV-1 or MERS-CoV spike.
  status: ''
  type: nanobody
  pdb: 6WAQ
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '200'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: VHH-72-FcM
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '70840'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: VHH-72-FcM
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '67870'
  epitope_class: ''
- references:
  - doi: 10.1080/19420862.2020.1778435
    refId: Sun20
    firstAuthor:
      surname: Sun
      givenNames: Zehua
    year: 2020
    journal: mAbs
  antibodies: VH-M397-Fc
  source: |-
    Human sdAb CDR2 and CDR3 VH phage display library selected for RBD binding.
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '1500'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: W25
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '147.3'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: W25
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '76.35'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: W25Fc
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '812.9'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: W25Fc
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '405.9'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: W25FcM
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '1507'
  epitope_class: ''
- references:
  - doi: 10.1038/s41598-021-82833-w
    refId: ValenzuelaNieto21
    firstAuthor:
      surname: Valenzuela Nieto
      givenNames: Guillermo
    year: 2021
    journal: Scientific Reports
    journalShort: Sci Rep
  antibodies: W25FcM
  source: |-
    alpaca nanobody, +/- Fc fusion, M suffix = monomer otherwise dimer
  status: ''
  type: nanobody
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '679.8'
  epitope_class: ''
- references:
  - doi: 10.1016/j.celrep.2021.108699
    refId: Zhou21
    firstAuthor:
      surname: Zhou
      givenNames: Yunjiao
    year: 2021
    journal: Cell Reports
  antibodies: XG005
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 6.1, PV
  epitope_class: ''
- references:
  - doi: 10.1016/j.celrep.2021.108699
    refId: Zhou21
    firstAuthor:
      surname: Zhou
      givenNames: Yunjiao
    year: 2021
    journal: Cell Reports
  antibodies: XG014
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: '5.1'
  epitope_class: ''
- references:
  - doi: 10.1016/j.celrep.2021.108699
    refId: Zhou21
    firstAuthor:
      surname: Zhou
      givenNames: Yunjiao
    year: 2021
    journal: Cell Reports
  antibodies: XG016
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 9.1, PV
  epitope_class: ''
- references:
  - doi: 10.1016/j.celrep.2021.108699
    refId: Zhou21
    firstAuthor:
      surname: Zhou
      givenNames: Yunjiao
    year: 2021
    journal: Cell Reports
  antibodies: XG027
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 15.7,PV
  epitope_class: ''
- references:
  - doi: 10.1016/j.celrep.2021.108699
    refId: Zhou21
    firstAuthor:
      surname: Zhou
      givenNames: Yunjiao
    year: 2021
    journal: Cell Reports
  antibodies: XG038
  status: ''
  type: mAb
  pdb: ''
  ighv: ''
  shm: ''
  cdrh3_len: ''
  iglv: ''
  ic50: 12.7, PV
  epitope_class: ''
